No heart attack risk from attention-deficit drugs: study

November 1, 2011

A major study of more than one million children and young adults has shown no higher risk of heart attack among those who take drugs for attention deficit hyperactivity disorder, a US study said Tuesday.

Ritalin and similar medicines that millions of children and teens take to curb hyperactivity and boost attention do not raise their risk of serious heart problems, the largest safety study of these drugs concludes.

Heart attacks, strokes and sudden death were very rare and no more common in children on the drugs than in kids not taking them, the federally funded study found. That was true even for children and young adults with a higher risk of heart problems - a group doctors have long worried about when prescribing these drugs.

"This study would suggest that their risk is remarkably low. And that's good news," said the study's leader, Dr. William Cooper, a pediatrics and preventive medicine professor at Vanderbilt University.

"Parents should be very reassured," said Dr. Laurel Leslie, a pediatrician at Tufts Medical Center in Boston who had no role in the study but served on a Food and Drug Administration advisory panel examining drugs for ADHD, or attention deficit-hyperactivity disorder.

The study was sponsored by the federal Agency for Healthcare Research and Quality and the FDA. Results were published online Tuesday by the New England Journal of Medicine. Results from similar studies of these medicines in adults are expected soon.

More than 5 million children in the United States have been diagnosed with ADHD, which hampers a child's ability to pay attention and control behavior. Although it seems counterintuitive, stimulant medications such as Ritalin, Adderall, Concerta and Strattera can help these children, and about 2.7 million of them are prescribed such drugs each year.

However, isolated reports of heart attacks and strokes in kids taking the drugs caused worry, and the Canadian government curbed use of one drug in 2006. The FDA added a black box warning to some ADHD drugs, and the American Heart Association gave the controversial advice in 2008 that it was reasonable to screen a child starting on such a drug with a heart EKG test.

"There's such strong feelings around these drugs" and whether they are overused in children who might be helped by behavioral therapy alone, Cooper said. "The potential safety questions have added another layer of concern."

His study was aimed at resolving the safety question. Researchers used medical records from four big health plans covering more than 1.2 million people ages 2 through 24. They found 81 cases of serious heart problems from 1998 through 2005 among all people in the study.

Those on ADHD medicines were no more likely to suffer a heart attack, stroke or sudden death than were non-users or former users of such drugs. More than half of children and young adults taking ADHD drugs used methylphenidate - generic Ritalin - and researchers saw no increased risk from that specific drug either.

"The good news is that it doesn't look like overall, there's an increase in cardiovascular events in kids who are on ADHD drugs," said Dr. Gordon Tomaselli, a Johns Hopkins University heart specialist and president of the American Heart Association. "The question parents should be asking themselves is, `Does my child really need this?'"

Cooper, the study's leader, and Leslie, the Boston pediatrician, defended the drugs' use, especially with careful medical monitoring and behavioral therapy.

"I take care of kids all the time who are helped by these drugs," Cooper said.

FDA spokeswoman Sandy Walsh said stimulants "should generally not be used in patients with serious heart problems, or for whom an increase in blood pressure or heart rate would be problematic."

Patients on ADHD medications also should be watched for changes in heart rate or blood pressure, she said.

The drugs cost from $40 to $100 a month.

Explore further: No increase in severe cardiovascular events for children, adolescents taking ADHD medications

More information: Study: www.nejm.org

shares

Related Stories

No increase in severe cardiovascular events for children, adolescents taking ADHD medications

May 16, 2011
Despite recent concerns that medications for attention deficit hyperactivity disorder (ADHD) could increase the risk of cardiovascular events in children and adolescents, an observational study conducted by researchers at ...

Mutant gene linked to ADHD

April 18, 2011
(PhysOrg.com) -- In a recent study published in Nature Medicine, Dr. Eunjin Kim from the Korea Advanced Institute of Science and Technology uncovers a genetic fault that triples the chances of a child having ADHD (Attention ...

ADHD symptoms worsen quality of life for individuals with autism

September 19, 2011
Research supported by the Autism Speaks Autism Treatment Network (ATN), demonstrating that symptoms of attention deficit and hyperactivity worsen quality of life for individuals with autism spectrum disorders (ASD), was presented ...

Recommended for you

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Discharge
not rated yet Nov 02, 2011
Riiiight...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.